DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

GenXAI Analytics Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 41 min ago·9 Oct 2026, 7:33 am

GenXAI Analytics

GenXAI Analytics Limited has submitted a certificate to the stock exchange to comply with SEBI's Depositories and Participants Regulations, 2018. This regulatory filing is a standard procedural requirement that confirms the company's adherence to the rules governing securities markets and depository participants.

For investors, this development is a routine administrative update rather than a significant market-moving event. It signals the company's commitment to maintaining good corporate governance and transparency. While it does not directly impact the company's financial performance, it ensures the stock continues to meet all regulatory compliance standards.

Investors should monitor the company's future quarterly results and business expansion plans to gauge its actual growth trajectory. This filing primarily serves as a confirmation of compliance, so it is not a signal to buy or sell the stock based on this news alone.